Deals
Teva Said to Plan Public Mylan Approach as Soon as Today
What Makes Mylan Worth $40.1B to Teva?
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. is preparing an unsolicited offer for rival Mylan NV, people with knowledge of the matter said, in what could be the drug industry’s largest takeover attempt this year.
The Israeli company could make a public bid for Mylan, which has a market value of $33.3 billion, as soon as Tuesday, the people said. Teva is working with Barclays Plc on the approach and has contacted other banks about financing any potential deal, they said, asking not to be identified as the information is confidential.